Cargando…
Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827157/ https://www.ncbi.nlm.nih.gov/pubmed/36073515 http://dx.doi.org/10.3324/haematol.2022.281386 |
_version_ | 1784867013635604480 |
---|---|
author | Kockerols, Camille C.B. Janssen, Jeroen J.W.M Blijlevens, Nicole M.A. Klein, Saskia K. van Hussen-Daenen, Laura G.M. van Gorkom, Gwendolyn G.Y. Smit, Willem M. van Balen, Peter Biemond, Bart J. Cruijsen, Marjan J. Corsten, Maarten F. te Boekhorst, Peter A.W. Koene, Harry R. van Sluis, Geerte L. Cornelissen, Jan J. Westerweel, Peter E. |
author_facet | Kockerols, Camille C.B. Janssen, Jeroen J.W.M Blijlevens, Nicole M.A. Klein, Saskia K. van Hussen-Daenen, Laura G.M. van Gorkom, Gwendolyn G.Y. Smit, Willem M. van Balen, Peter Biemond, Bart J. Cruijsen, Marjan J. Corsten, Maarten F. te Boekhorst, Peter A.W. Koene, Harry R. van Sluis, Geerte L. Cornelissen, Jan J. Westerweel, Peter E. |
author_sort | Kockerols, Camille C.B. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9827157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-98271572023-01-20 Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population Kockerols, Camille C.B. Janssen, Jeroen J.W.M Blijlevens, Nicole M.A. Klein, Saskia K. van Hussen-Daenen, Laura G.M. van Gorkom, Gwendolyn G.Y. Smit, Willem M. van Balen, Peter Biemond, Bart J. Cruijsen, Marjan J. Corsten, Maarten F. te Boekhorst, Peter A.W. Koene, Harry R. van Sluis, Geerte L. Cornelissen, Jan J. Westerweel, Peter E. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-09-08 /pmc/articles/PMC9827157/ /pubmed/36073515 http://dx.doi.org/10.3324/haematol.2022.281386 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letter to the Editor Kockerols, Camille C.B. Janssen, Jeroen J.W.M Blijlevens, Nicole M.A. Klein, Saskia K. van Hussen-Daenen, Laura G.M. van Gorkom, Gwendolyn G.Y. Smit, Willem M. van Balen, Peter Biemond, Bart J. Cruijsen, Marjan J. Corsten, Maarten F. te Boekhorst, Peter A.W. Koene, Harry R. van Sluis, Geerte L. Cornelissen, Jan J. Westerweel, Peter E. Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population |
title | Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population |
title_full | Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population |
title_fullStr | Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population |
title_full_unstemmed | Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population |
title_short | Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population |
title_sort | treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827157/ https://www.ncbi.nlm.nih.gov/pubmed/36073515 http://dx.doi.org/10.3324/haematol.2022.281386 |
work_keys_str_mv | AT kockerolscamillecb treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT janssenjeroenjwm treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT blijlevensnicolema treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT kleinsaskiak treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT vanhussendaenenlauragm treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT vangorkomgwendolyngy treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT smitwillemm treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT vanbalenpeter treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT biemondbartj treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT cruijsenmarjanj treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT corstenmaartenf treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT teboekhorstpeteraw treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT koeneharryr treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT vansluisgeertel treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT cornelissenjanj treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation AT westerweelpetere treatmentpatternsandclinicaloutcomesofasciminibinarealworldmultiresistantchronicmyeloidleukemiapatientpopulation |